Practice
Clinical updates, guidelines, prescribing, and practical medicine
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
More form Practice
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight…